Article Text

Download PDFPDF
Cohort study
Short- and long-term treatment with non-steroidal anti-inflammatory drugs increases risk of death or recurrent MI in those with previous MI
  1. Anjan K Chakrabarti,
  2. C Michael Gibson
  1. Department of Cardiology, Beth Israel Deaconess Medical Center, Boston Massachusetts, USA
  1. Correspondence to: Anjan K Chakrabarti
    Beth Israel Deaconess Medical Center, 185 Pilgrim Road, Baker 4, Boston MA 02215, USA; akchakra{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Commentary on: OpenUrlAbstract/FREE Full Text


Non-steroidal anti-inflammatory drugs (NSAIDs) have been implicated in causing negative cardiovascular outcomes, particularly in coronary artery disease (CAD) patients who have had a prior myocardial infarction (MI). In fact, as Schjerning Olsen and colleagues point out, current guidelines give the rather nebulous recommendation that duration of NSAID therapy should be as short as possible in CAD patients.1

The study by Schjerning Olsen and colleagues seeks to characterise the association between NSAID treatment duration and risk of cardiovascular disease. Although selective cyclooxygenase 2 inhibitors (COX-2) such as rofecoxib and valdecoxib have received notoriety and …

View Full Text


  • Competing interests None.